Source: Annual Congress 2008 - Comorbidities in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Flores-Trujillo, A. Ramirez-Venegas, R. J. Hernandez-Zenteno, C. Sanchez-Romero, J. Regalado-Pineda, R. H. Sansores-Martinez (Mexico City DF, Mexico). The blue bloater phenotype in COPD is associated with metabolic syndrome. Eur Respir J 2008; 32: Suppl. 52, 4508

Member's Comments

No comment yet.

Related content which might interest you: Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype? Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 The association between metabolic syndrome, obesity and asthma Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008 Evaluation of association between COPD and metabolic syndrome, and insulin resistance Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Prevalence of metabolic syndrome in smokers with and without COPD Source: Annual Congress 2008 - COPD and miscellaneous Year: 2008 Asthma-COPD overlap syndrome shows favorable prognosis compared to pure COPD in Korean COPD cohort Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 The asthma–COPD overlap syndrome Source: Eur Respir Monogr 2015; 69: 85-95 Year: 2015 Metabolic syndrome in patients with stable COPD Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Do respiratory patients with chronic hypoxaemia favour the colour blue? Source: Eur Respir J 2006; 28: Suppl. 50, 863s Year: 2006 Prevalence of the metabolic syndrome (MS) in mediterranean patients with suspected OSAS Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea Year: 2008 Metabolic syndrome and COPD Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 The lack of evidence based knowledge of metabolic syndrome in obesity hypoventilation syndrome Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Clinical differences of COPD patients with and without metabolic syndrome Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 What constituents of the metabolic syndrome are prevalent in the sleep apnoea syndrome? Source: Eur Respir J 2005; 26: Suppl. 49, 568s Year: 2005 Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 The clinical and genetic features of COPD-asthma overlap syndrome Source: Eur Respir J 2014; 44: 341-350 Year: 2014 Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: A preliminary study Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Metabolic syndrome and chronic diseases in COPD Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012